Management of malignant airway obstruction: Clinical and dosimetric considerations using an iridium-192 afterloading technique in conjunction with the neodymium-YAG laser

Mark F. Schray, John C. McDougall, Alvaro Martinez, Gregory K. Edmundson, Denis Cortese

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Fourteen patients with malignant airway obstruction have had 21 placements of a flexible nylon catheter for afterloading Iridium-192 using the flexible fiberoptic bronchoscope. Prescribed therapy was completed in 13 patients (18 courses). All patients had prior full-dose external irradiation, and no effective surgical or chemotherapeutic options remained. While many have had a trial of neodymium-YAG (yttrium-aluminum-garnet) laser therapy alone, eight patients received laser treatment one to three weeks prior to planned brachytherapy to provide immediate relief of symptoms and/or facilitate access and safe catheter placement. Most patients (64%) had recurrent squamous cell lung cancer. A dose of 3000 cGy is currently specified to 5 mm and 10 mm in the bronchus and trachea, respectively. Nine of the 13 treated patients have had follow-up bronchoscopy at approximately three months post-treatment with improvement documented in seven and progression in two patients. One patient was clinically improved without follow-up bronchoscopy, and three patients have had insufficient follow-up. A single patient treated with laser and 6000 rad at 5 mm developed a bronchoesophageal fistula. No other complication has been observed. The technique is simple and safe with the use of laser therapy when needed and appears to offer effective palliation in most patients even when standard therapy is exhausted.

Original languageEnglish (US)
Pages (from-to)403-409
Number of pages7
JournalInternational Journal of Radiation Oncology, Biology, Physics
Volume11
Issue number2
DOIs
StatePublished - 1985
Externally publishedYes

Fingerprint

neodymium lasers
Neodymium
Iridium
Solid-State Lasers
Airway Obstruction
iridium
YAG lasers
therapy
Laser Therapy
Bronchoscopy
yttrium-aluminum garnet
lasers
Lasers
Catheters
bronchi
trachea
Bronchoscopes
Squamous Cell Neoplasms
dosage
Nylon (trademark)

Keywords

  • Brachytherapy
  • Endobronchial irradiation
  • Laser therapy
  • Lung neoplasm

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Management of malignant airway obstruction : Clinical and dosimetric considerations using an iridium-192 afterloading technique in conjunction with the neodymium-YAG laser. / Schray, Mark F.; McDougall, John C.; Martinez, Alvaro; Edmundson, Gregory K.; Cortese, Denis.

In: International Journal of Radiation Oncology, Biology, Physics, Vol. 11, No. 2, 1985, p. 403-409.

Research output: Contribution to journalArticle

@article{b313c6688d884d7998c4215fe5b28c7c,
title = "Management of malignant airway obstruction: Clinical and dosimetric considerations using an iridium-192 afterloading technique in conjunction with the neodymium-YAG laser",
abstract = "Fourteen patients with malignant airway obstruction have had 21 placements of a flexible nylon catheter for afterloading Iridium-192 using the flexible fiberoptic bronchoscope. Prescribed therapy was completed in 13 patients (18 courses). All patients had prior full-dose external irradiation, and no effective surgical or chemotherapeutic options remained. While many have had a trial of neodymium-YAG (yttrium-aluminum-garnet) laser therapy alone, eight patients received laser treatment one to three weeks prior to planned brachytherapy to provide immediate relief of symptoms and/or facilitate access and safe catheter placement. Most patients (64{\%}) had recurrent squamous cell lung cancer. A dose of 3000 cGy is currently specified to 5 mm and 10 mm in the bronchus and trachea, respectively. Nine of the 13 treated patients have had follow-up bronchoscopy at approximately three months post-treatment with improvement documented in seven and progression in two patients. One patient was clinically improved without follow-up bronchoscopy, and three patients have had insufficient follow-up. A single patient treated with laser and 6000 rad at 5 mm developed a bronchoesophageal fistula. No other complication has been observed. The technique is simple and safe with the use of laser therapy when needed and appears to offer effective palliation in most patients even when standard therapy is exhausted.",
keywords = "Brachytherapy, Endobronchial irradiation, Laser therapy, Lung neoplasm",
author = "Schray, {Mark F.} and McDougall, {John C.} and Alvaro Martinez and Edmundson, {Gregory K.} and Denis Cortese",
year = "1985",
doi = "10.1016/0360-3016(85)90165-8",
language = "English (US)",
volume = "11",
pages = "403--409",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Management of malignant airway obstruction

T2 - Clinical and dosimetric considerations using an iridium-192 afterloading technique in conjunction with the neodymium-YAG laser

AU - Schray, Mark F.

AU - McDougall, John C.

AU - Martinez, Alvaro

AU - Edmundson, Gregory K.

AU - Cortese, Denis

PY - 1985

Y1 - 1985

N2 - Fourteen patients with malignant airway obstruction have had 21 placements of a flexible nylon catheter for afterloading Iridium-192 using the flexible fiberoptic bronchoscope. Prescribed therapy was completed in 13 patients (18 courses). All patients had prior full-dose external irradiation, and no effective surgical or chemotherapeutic options remained. While many have had a trial of neodymium-YAG (yttrium-aluminum-garnet) laser therapy alone, eight patients received laser treatment one to three weeks prior to planned brachytherapy to provide immediate relief of symptoms and/or facilitate access and safe catheter placement. Most patients (64%) had recurrent squamous cell lung cancer. A dose of 3000 cGy is currently specified to 5 mm and 10 mm in the bronchus and trachea, respectively. Nine of the 13 treated patients have had follow-up bronchoscopy at approximately three months post-treatment with improvement documented in seven and progression in two patients. One patient was clinically improved without follow-up bronchoscopy, and three patients have had insufficient follow-up. A single patient treated with laser and 6000 rad at 5 mm developed a bronchoesophageal fistula. No other complication has been observed. The technique is simple and safe with the use of laser therapy when needed and appears to offer effective palliation in most patients even when standard therapy is exhausted.

AB - Fourteen patients with malignant airway obstruction have had 21 placements of a flexible nylon catheter for afterloading Iridium-192 using the flexible fiberoptic bronchoscope. Prescribed therapy was completed in 13 patients (18 courses). All patients had prior full-dose external irradiation, and no effective surgical or chemotherapeutic options remained. While many have had a trial of neodymium-YAG (yttrium-aluminum-garnet) laser therapy alone, eight patients received laser treatment one to three weeks prior to planned brachytherapy to provide immediate relief of symptoms and/or facilitate access and safe catheter placement. Most patients (64%) had recurrent squamous cell lung cancer. A dose of 3000 cGy is currently specified to 5 mm and 10 mm in the bronchus and trachea, respectively. Nine of the 13 treated patients have had follow-up bronchoscopy at approximately three months post-treatment with improvement documented in seven and progression in two patients. One patient was clinically improved without follow-up bronchoscopy, and three patients have had insufficient follow-up. A single patient treated with laser and 6000 rad at 5 mm developed a bronchoesophageal fistula. No other complication has been observed. The technique is simple and safe with the use of laser therapy when needed and appears to offer effective palliation in most patients even when standard therapy is exhausted.

KW - Brachytherapy

KW - Endobronchial irradiation

KW - Laser therapy

KW - Lung neoplasm

UR - http://www.scopus.com/inward/record.url?scp=0021948539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021948539&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(85)90165-8

DO - 10.1016/0360-3016(85)90165-8

M3 - Article

C2 - 2579051

AN - SCOPUS:0021948539

VL - 11

SP - 403

EP - 409

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -